misc. zymoplasm ; fibrin ferment
...1+2)是凝血酶原向凝血酶转化时的裂解产物,纤维蛋白肽A(FPA)是凝血酶作用于纤维蛋白原产生的裂解产物,凝血酶-抗凝血酶复合物(TAT)是凝血酶与抗凝血酶Ⅲ特异结合的产物,三者均是反映凝血酶形成的特异、敏感指标;DD是胶联纤维蛋白溶解的特异产物,反映继发纤溶的激...
基于124个网页-相关网页
凝血酶时间 TT ; thrombin time ; tempo di trombina ; activated partial thromboplastin time
凝血酶原 [生化] prothrombin ; DCP ; serozyme ; thrombinogen
凝血酶原时间 PT ; [病理] prothrombin time ; activated partial thromboplastin time ; APTT
抗凝血酶 [生化] antithrombin ; antithrombi ; ATIII ; G ANTITHROMBIN III impurity
凝血酶原活动度 PTA ; prothrombin activity ; prothrombin time activity percentage ; prothrombin time activity
抗凝血酶III ATIII ; antithrombin III
抗凝血酶受体 ATR
凝血酶原复合物 PCC ; PPSB ; Prothrombin Complex ; Prothrombin Complex Concentrate
异常凝血酶原 APT ; DCP ; PIVKA ; II
利用毕赤酵母表达具有生物学活性的蛇毒类凝血酶安克洛。
Express ancrod, a snake venom thrombin-like enzyme, in methylotrophic yeast Pichia pastoris.
血栓调节蛋白可完全抑制凝血酶和利斯托司汀诱导的血小板聚集。
Thrombomodulin can entirely inhibit thrombin and ristocetin-induced platelet aggregation.
目的探讨瘤腔内注射凝血酶治疗股动脉假性动脉瘤的安全性和可行性。
Objective To evaluate the feasibility and safety of ultrasound-localized percutaneous thrombin injection (ULTI) for the treatment of iatrogenic femoral pseudoaneurysm.
应用推荐